Fund
BOLD Longevity Growth
BOLD Longevity Growth took part in the round of Matchpoint Therapeutics (150 M$, Series B) on 7 October 2026. It is the only health round Bolus has logged for it so far.
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 1
- Lead
- 0
- New entries
- 1
- Follow ons
- 0
- Latest operation
- 7 October 2026
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 07 Oct | United States | Series B | 150 M$ | Participant |
Co investors 5 funds crossed
- BB Biotech 1 operation
- Invus 1 operation
- Nextech Invest 1 operation
- Norwest 1 operation
- T1D Fund 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: United States.